This research study is assessing the feasibility of reduced intensity allogeneic
hematopoietic stem cell transplantation (HSCT) as a possible treatment for relapsed /
refractory non-Hodgkin lymphoma involving the central nervous system (CNS). HSCT is the
transplantation of stem cells, usually derived from bone marrow, peripheral blood, or
umbilical cord blood.